Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Anderegg

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Diagnostic Microbiology and Infectious Disease|June 8, 2002
AZD2563, a new oxazolidinone: bactericidal activity and synergy studies combined with gentamicin or vancomycin against staphylococci and streptococcal strainsR N Jones, T R Anderegg, L M Deshpande
Journal of Clinical Microbiology|June 7, 2003
Initial quality control evaluations for susceptibility testing of Dalbavancin (BI397), an investigational glycopeptide with potent gram-positive activityTamara R Anderegg, Douglas J Biedenbach, Ronald N Jones, et al.
International Journal of Antimicrobial Agents|July 5, 2003
Quality control guidelines for MIC susceptibility testing of NVP PDF-713: a novel peptide deformylase inhibitorTamara R Anderegg, Douglas J Biedenbach, Ronald N Jones, et al.
Journal of Clinical Microbiology|July 10, 2004
Quality control guidelines for BAL9141 (Ro 63-9141), an investigational cephalosporin, when reference MIC and standardized disk diffusion susceptibility test methods are usedT R Anderegg, R N Jones, H S Sader, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 2002
In vitro evaluation of AZD2563, a new oxazolidinone, tested against beta-haemolytic and viridans group streptococciTamara R Anderegg, Douglas J Biedenbach, Ronald N Jones
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2003
Validation of commercial dry-form broth microdilution panels for susceptibility testing of AZD2563, a new long-acting oxazolidinoneR N Jones, T R Anderegg, D J Biedenbach
Antimicrobial Agents and Chemotherapy|July 18, 2002
In vitro evaluation of AZD2563, a novel oxazolidinone, against 603 recent staphylococcal isolatesTamara R Anderegg, Douglas J Biedenbach, Ronald N Jones
The Journal of the Western Society of Periodontology/Periodontal Abstracts|January 11, 1991
Comparison of presurgical and surgical measurements of maxillary molar furcations--a preliminary studyC R Anderegg, D G Metzler, J L Gray, et al.
The Biochemical Journal|September 15, 1992
Human interleukin-5 expressed in Escherichia coli has N-terminal modificationsK Rose, P O Regamey, R Anderegg, et al.
Journal of Periodontology|April 1, 1991
Clinical evaluation of the use of decalcified freeze-dried bone allograft with guided tissue regeneration in the treatment of molar furcation invasionsC R Anderegg, S J Martin, J L Gray, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Diagnostic Microbiology and Infectious Disease|June 8, 2002
AZD2563, a new oxazolidinone: bactericidal activity and synergy studies combined with gentamicin or vancomycin against staphylococci and streptococcal strainsR N Jones, T R Anderegg, L M Deshpande
Journal of Clinical Microbiology|June 7, 2003
Initial quality control evaluations for susceptibility testing of Dalbavancin (BI397), an investigational glycopeptide with potent gram-positive activityTamara R Anderegg, Douglas J Biedenbach, Ronald N Jones, et al.
International Journal of Antimicrobial Agents|July 5, 2003
Quality control guidelines for MIC susceptibility testing of NVP PDF-713: a novel peptide deformylase inhibitorTamara R Anderegg, Douglas J Biedenbach, Ronald N Jones, et al.
Journal of Clinical Microbiology|July 10, 2004
Quality control guidelines for BAL9141 (Ro 63-9141), an investigational cephalosporin, when reference MIC and standardized disk diffusion susceptibility test methods are usedT R Anderegg, R N Jones, H S Sader, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 2002
In vitro evaluation of AZD2563, a new oxazolidinone, tested against beta-haemolytic and viridans group streptococciTamara R Anderegg, Douglas J Biedenbach, Ronald N Jones
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2003
Validation of commercial dry-form broth microdilution panels for susceptibility testing of AZD2563, a new long-acting oxazolidinoneR N Jones, T R Anderegg, D J Biedenbach
Antimicrobial Agents and Chemotherapy|July 18, 2002
In vitro evaluation of AZD2563, a novel oxazolidinone, against 603 recent staphylococcal isolatesTamara R Anderegg, Douglas J Biedenbach, Ronald N Jones
The Journal of the Western Society of Periodontology/Periodontal Abstracts|January 11, 1991
Comparison of presurgical and surgical measurements of maxillary molar furcations--a preliminary studyC R Anderegg, D G Metzler, J L Gray, et al.
The Biochemical Journal|September 15, 1992
Human interleukin-5 expressed in Escherichia coli has N-terminal modificationsK Rose, P O Regamey, R Anderegg, et al.
Journal of Periodontology|April 1, 1991
Clinical evaluation of the use of decalcified freeze-dried bone allograft with guided tissue regeneration in the treatment of molar furcation invasionsC R Anderegg, S J Martin, J L Gray, et al.
Pageof 4